{"id":"https://openalex.org/W2020118281","doi":"https://doi.org/10.1007/s00213-011-2365-6","title":"Translational PK\u2013PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576","display_name":"Translational PK\u2013PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576","publication_year":2011,"publication_date":"2011-06-06","ids":{"openalex":"https://openalex.org/W2020118281","doi":"https://doi.org/10.1007/s00213-011-2365-6","mag":"2020118281","pmid":"https://pubmed.ncbi.nlm.nih.gov/21647578"},"language":"en","primary_location":{"id":"doi:10.1007/s00213-011-2365-6","doi":"https://doi.org/10.1007/s00213-011-2365-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00213-011-2365-6","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018848503","display_name":"Roberta Bursi","orcid":"https://orcid.org/0000-0001-9118-3786","observed_orcids":["https://orcid.org/0000-0001-9118-3786"]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Roberta Bursi","raw_affiliation_strings":["Clinical PK-PD, Dev. DMPK, MSD, PO Box 20, Oss, BH, 5340, The Netherlands. roberta.bursi@merck.com","Clinical PK-PD, Dev. DMPK, MSD, PO Box\u00a020, Oss, BH, 5340, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical PK-PD, Dev. DMPK, MSD, PO Box 20, Oss, BH, 5340, The Netherlands. roberta.bursi@merck.com","institution_ids":["https://openalex.org/I4210162999"]},{"raw_affiliation_string":"Clinical PK-PD, Dev. DMPK, MSD, PO Box\u00a020, Oss, BH, 5340, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021526672","display_name":"G\u00fcl Erdemli","orcid":"https://orcid.org/0000-0003-4677-2914","observed_orcids":["https://orcid.org/0000-0003-4677-2914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gul Erdemli","raw_affiliation_strings":["Department of Molecular Pharmacology, Schering-Plough, Newhouse, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pharmacology, Schering-Plough, Newhouse, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Campbell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Campbell","raw_affiliation_strings":["Department of Pharmacology, Schering-Plough, Newhouse, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Schering-Plough, Newhouse, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108188701","display_name":"Matthew M. Hutmacher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew M. Hutmacher","raw_affiliation_strings":["Ann Arbor Pharmacometrics Group, Ann Arbor, MI, 48104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ann Arbor Pharmacometrics Group, Ann Arbor, MI, 48104, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058873524","display_name":"Thomas Kerbusch","orcid":"https://orcid.org/0000-0003-4564-5614","observed_orcids":["https://orcid.org/0000-0003-4564-5614"]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Thomas Kerbusch","raw_affiliation_strings":["Department of M&S, Early Stage Dev., MSD, Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of M&S, Early Stage Dev., MSD, Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040623262","display_name":"David\u00a0C. Spanswick","orcid":"https://orcid.org/0000-0002-8129-8173","observed_orcids":["https://orcid.org/0000-0002-8129-8173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Spanswick","raw_affiliation_strings":["NeuroSolutions Ltd, Coventry, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeuroSolutions Ltd, Coventry, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056749202","display_name":"Ross Jeggo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ross Jeggo","raw_affiliation_strings":["NeuroSolutions Ltd, Coventry, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeuroSolutions Ltd, Coventry, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025495039","display_name":"Kari R. Nations","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kari R. Nations","raw_affiliation_strings":["Clinical Research, Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065632651","display_name":"Peter Dogterom","orcid":"https://orcid.org/0000-0001-8447-2934","observed_orcids":["https://orcid.org/0000-0001-8447-2934"]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter Dogterom","raw_affiliation_strings":["Early Stage Development, MSD, Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Stage Development, MSD, Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023676126","display_name":"Jacques Schipper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162999","display_name":"MSD (Netherlands)","ror":"https://ror.org/05y28vr04","country_code":"NL","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210162999"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jacques Schipper","raw_affiliation_strings":["Project and Pipeline Management, MSD, Oss, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Project and Pipeline Management, MSD, Oss, the Netherlands","institution_ids":["https://openalex.org/I4210162999"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110733179","display_name":"Mohammed Shahid","orcid":"https://orcid.org/0009-0009-3533-6368","observed_orcids":["https://orcid.org/0009-0009-3533-6368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Shahid","raw_affiliation_strings":["Department of Molecular Pharmacology, MSD, Newhouse, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pharmacology, MSD, Newhouse, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018848503"],"corresponding_institution_ids":["https://openalex.org/I4210162999"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.4574,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.77565963,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"218","issue":"4","first_page":"713","last_page":"724"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.09269999712705612,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.7730000019073486},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-pharmacokinetics","display_name":"cerebrospinal fluid pharmacokinetics","score":0.9739999771118164},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.7440000176429749},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.9463791847229004},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7562921643257141},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6477638483047485},{"id":"https://openalex.org/C164718446","wikidata":"https://www.wikidata.org/wiki/Q7234839","display_name":"Potentiator","level":2,"score":0.6442133188247681},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.6235387325286865},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.5264652371406555},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5121183395385742},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4924562871456146},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47449517250061035},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4471096992492676},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.44096407294273376},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3255329132080078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31250566244125366},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.18847942352294922},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16313102841377258}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018350","descriptor_name":"alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057170","descriptor_name":"Translational Research, Biomedical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00213-011-2365-6","doi":"https://doi.org/10.1007/s00213-011-2365-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00213-011-2365-6","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:21647578","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21647578","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Controlled Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1525774039","https://openalex.org/W1526674447","https://openalex.org/W1545157894","https://openalex.org/W1589107006","https://openalex.org/W1980970141","https://openalex.org/W1988985727","https://openalex.org/W2001055525","https://openalex.org/W2001638562","https://openalex.org/W2004565197","https://openalex.org/W2009309964","https://openalex.org/W2009770956","https://openalex.org/W2013274401","https://openalex.org/W2016288186","https://openalex.org/W2016971764","https://openalex.org/W2021069714","https://openalex.org/W2023989346","https://openalex.org/W2030254267","https://openalex.org/W2032458901","https://openalex.org/W2043052878","https://openalex.org/W2043576181","https://openalex.org/W2043660784","https://openalex.org/W2051942403","https://openalex.org/W2058128885","https://openalex.org/W2061731402","https://openalex.org/W2062856075","https://openalex.org/W2065521724","https://openalex.org/W2066941852","https://openalex.org/W2069644503","https://openalex.org/W2076472674","https://openalex.org/W2092005835","https://openalex.org/W2098870590","https://openalex.org/W2099280886","https://openalex.org/W2111212725","https://openalex.org/W2115922181","https://openalex.org/W2116624325","https://openalex.org/W2122532139","https://openalex.org/W2137107827","https://openalex.org/W2140899588","https://openalex.org/W2141310323","https://openalex.org/W2148920664","https://openalex.org/W2151729293","https://openalex.org/W2163815564","https://openalex.org/W2169860789","https://openalex.org/W4406059073"],"related_works":["https://openalex.org/W1782499039","https://openalex.org/W2284698163","https://openalex.org/W2117061396","https://openalex.org/W7097969766","https://openalex.org/W2912966222","https://openalex.org/W2042316297","https://openalex.org/W2912040393","https://openalex.org/W2512992921","https://openalex.org/W2481676815","https://openalex.org/W135988513"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}